Investor Relations Home

Webcast ImageWebcast
Q3 2014 Masimo Corporation Earnings Conference Call (Live)
10/29/14 at 1:30 p.m. PT
2011 Annual Report
2012 Annual Report
2011 Annual Report
2011 Annual Report
2009 Annual Report
2009 Annual Report
2008 Annual Report
2008 Annual Report
2007 Annual Report
2007 Annual Report
Stock Quote
MASI (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Change (%) Stock is Down 0.07 (0.32%)
Data as of 10/22/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Online Investor Kit
Masimo Reports Second Quarter 2014 Financial Results
2013 Form 10K
2014 Proxy Statement
2012 Annual Report
Corporate Profile
We are a global medical technology company that develops, manufactures, and markets a variety of noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996.

Our core business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, kno... 
More >>
Upcoming EventsMore >>
DateTitleAdd to Calendar HelpRemind MePrior to Event
10/29/14 1:30 p.m. PTQ3 2014 Masimo Corporation Earnings Conference CallAdd Q3 2014 Masimo Corporation Earnings Conference Call to Calendar days
Enter your e-mail address 
Recent News
| More >>
Masimo to Report Third Quarter 2014 Financial Results After Market Close on Wednesday, October 29th - 10/17/14
Conference Call and Webcast to Begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, CA -- (Marketwired) -- 10/17/14 -- Masimo (NASDAQ: MASI) announced today that it will release financial results for the third quarter ended September 27, 2014, after the m... More >>
Two New Clinical Studies Show Masimo Noninvasive Hemoglobin (SpHb(R)) Demonstrated Similar Precision as Hemoglobin From Point of Care Devices - 10/16/14
IRVINE, CA -- (Marketwired) -- 10/16/14 -- Masimo (NASDAQ: MASI) announced two new studies today that showed that noninvasive hemoglobin (SpHb®) demonstrated similar accuracy as hemoglobin measured by invasive hemoglobin analyzers when both SpHb and... More >>
New Clinical Study Presented at the American Society of Anesthesiologists Annual Meeting Shows Benefit of Oxygen Reserve Index(TM), ORI(TM) - 10/15/14
The Study Was Among 12 Selected From More Than 1,000 as One of ASA's Best Abstracts IRVINE, CA -- (Marketwired) -- 10/15/14 -- Masimo (NASDAQ: MASI) announced today that a new clinical study evaluating Masimo's latest noninvasive patient monitorin... More >>
Retrospective Study of Enhanced Recovery After Surgery Program for Patients Undergoing Colorectal Surgery, Which Included Fluid Therapy Tailored to Masimo's PVI(R), Showed Reduced Length of Stay and Cost Savings - 10/14/14
Findings Presented at American Society of Anesthesiologists Annual Meeting IRVINE, CA -- (Marketwired) -- 10/14/14 -- Masimo (NASDAQ: MASI) announced today the results of a retrospective study of an Enhanced Recovery After Surgery (ERAS) program i... More >>
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Masimo Corporation posts new information to the site. Just enter your e-mail address and click Submit.

To request a copy of the Annual Report, click here.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.